Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications

Overview

Journal J Soc Cardiovasc Angiogr Interv

Specialty Cardiology & Vascular Diseases

Date 2024 Aug 12

PMID 39130710

Authors

Daniele Giacoppo

Jorge Saucedo

Bruno Scheller

Affiliations

Soon will be listed here.

Abstract

Drug-coated balloons are approved outside the United States, not only for the treatment of peripheral arteries but also for coronary arteries. This review describes the technological basics, the scenarios of clinical application, and the current available data from clinical trials for the different coronary indications.

Citing Articles

Everolimus-encapsulation in Pluronic P123 self-assembled micelles as drug delivery systems for drug-coated balloons.

Akrami-Hasan-Kohal M, Chouchou A, Blanquer S, Sharkawi T Int J Pharm X. 2024; 7:100230.

PMID: 39668884 PMC: 11636783. DOI: 10.1016/j.ijpx.2024.100230.

Application of Drug-Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions.

Somsen Y, Rissanen T, Hoek R, Ris T, J Stuijfzand W, Nap A Catheter Cardiovasc Interv. 2024; 105(2):494-516.

PMID: 39660933 PMC: 11788978. DOI: 10.1002/ccd.31316.

Factors influencing coronary artery target lesion revascularization after drug-coated balloon angioplasty.

Undarsa A, Saboe A, Tiksnadi B, Akbar M, Yahya A Front Cardiovasc Med. 2024; 11():1387074.

PMID: 38818212 PMC: 11137689. DOI: 10.3389/fcvm.2024.1387074.

Current Management of In-Stent Restenosis.

Giacoppo D, Mazzone P, Capodanno D J Clin Med. 2024; 13(8).

PMID: 38673650 PMC: 11050960. DOI: 10.3390/jcm13082377.

References

Jeger R, Eccleshall S, Wan Ahmad W, Ge J, Poerner T, Shin E . Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group. JACC Cardiovasc Interv. 2020; 13(12):1391-1402. DOI: 10.1016/j.jcin.2020.02.043. View

Cortese B, Testa L, di Palma G, Heang T, Bossi I, Nuruddin A . Clinical performance of a novel sirolimus-coated balloon in coronary artery disease: EASTBOURNE registry. J Cardiovasc Med (Hagerstown). 2020; 22(2):94-100. DOI: 10.2459/JCM.0000000000001070. View

Rittger H, Waliszewski M, Brachmann J, Hohenforst-Schmidt W, Ohlow M, Brugger A . Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous.... JACC Cardiovasc Interv. 2015; 8(13):1695-700. DOI: 10.1016/j.jcin.2015.07.023. View

Funatsu A, Nakamura S, Inoue N, Nanto S, Nakamura M, Iwabuchi M . A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients with small vessel disease. Clin Res Cardiol. 2017; 106(10):824-832. DOI: 10.1007/s00392-017-1126-x. View

van der Heijden L, Kok M, Danse P, Schramm A, Hartmann M, Lowik M . Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial. Am Heart J. 2016; 176:28-35. DOI: 10.1016/j.ahj.2016.02.020. View

Alfonso F, Perez-Vizcayno M, Cardenas A, Garcia Del Blanco B, Garcia-Touchard A, Lopez-Minguez J . A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial. J Am Coll Cardiol. 2015; 66(1):23-33. DOI: 10.1016/j.jacc.2015.04.063. View

Elgendy I, Gad M, Elgendy A, Mahmoud A, Mahmoud A, Cuesta J . Clinical and Angiographic Outcomes With Drug-Coated Balloons for De Novo Coronary Lesions: A Meta-Analysis of Randomized Clinical Trials. J Am Heart Assoc. 2020; 9(10):e016224. PMC: 7660863. DOI: 10.1161/JAHA.120.016224. View

Lee J, Rhee T, Hahn J, Hwang D, Park J, Park K . Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry. Int J Cardiol. 2017; 230:181-190. DOI: 10.1016/j.ijcard.2016.12.176. View

Leone P, Mangieri A, Regazzoli D, Laricchia A, Khokhar A, Rossi M . Drug-Coated Balloon Angioplasty Guided by Postpercutaneous Coronary Intervention Pressure Gradient: The REDUCE-STENT Retrospective Registry. JACC Cardiovasc Interv. 2023; 16(3):363-365. DOI: 10.1016/j.jcin.2022.09.054. View

10.

Widder J, Cortese B, Levesque S, Berliner D, Eccleshall S, Graf K . Coronary artery treatment with a urea-based paclitaxel-coated balloon: the European-wide FALCON all-comers DCB Registry (FALCON Registry). EuroIntervention. 2018; 15(4):e382-e388. DOI: 10.4244/EIJ-D-18-00261. View

11.

Cortese B, di Palma G, Garcia Guimaraes M, Piraino D, Orrego P, Buccheri D . Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial. JACC Cardiovasc Interv. 2020; 13(24):2840-2849. DOI: 10.1016/j.jcin.2020.08.035. View

12.

Rocha-Singh K, Duval S, Jaff M, Schneider P, Ansel G, Lyden S . Mortality and Paclitaxel-Coated Devices: An Individual Patient Data Meta-Analysis. Circulation. 2020; 141(23):1859-1869. PMC: 8029645. DOI: 10.1161/CIRCULATIONAHA.119.044697. View

13.

Clever Y, Peters D, Calisse J, Bettink S, Berg M, Sperling C . Novel Sirolimus-Coated Balloon Catheter: In Vivo Evaluation in a Porcine Coronary Model. Circ Cardiovasc Interv. 2016; 9(4):e003543. DOI: 10.1161/CIRCINTERVENTIONS.115.003543. View

14.

Wessely R, Schomig A, Kastrati A . Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different. J Am Coll Cardiol. 2006; 47(4):708-14. DOI: 10.1016/j.jacc.2005.09.047. View

15.

Niehe S, Vos N, van der Schaaf R, Amoroso G, Herrman J, Patterson M . Two-Year Clinical Outcomes of the REVELATION Study: Sustained Safety and Feasibility of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction. J Invasive Cardiol. 2021; 34(1):E39-E42. DOI: 10.25270/jic/20.00741. View

16.

Kastrati A, Dibra A, Eberle S, Mehilli J, de Lezo J, Goy J . Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA. 2005; 294(7):819-25. DOI: 10.1001/jama.294.7.819. View

17.

Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G . Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004; 110(7):810-4. DOI: 10.1161/01.CIR.0000138929.71660.E0. View

18.

Varenne O, Cook S, Sideris G, Kedev S, Cuisset T, Carrie D . Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet. 2017; 391(10115):41-50. DOI: 10.1016/S0140-6736(17)32713-7. View

19.

Creel C, Lovich M, Edelman E . Arterial paclitaxel distribution and deposition. Circ Res. 2000; 86(8):879-84. DOI: 10.1161/01.res.86.8.879. View

20.

Akiyama T, Moussa I, Reimers B, Ferraro M, Kobayashi Y, Blengino S . Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol. 1998; 32(6):1610-8. DOI: 10.1016/s0735-1097(98)00444-6. View